Kumar Hermant
Known title: Chief Mfgr & Tech OfficerCIK: 0001884546
Associated companies
Transaction History
| GNPX | ▲ Buy | Grant | 200,000 | $0 | 2/18/2023 | View on chart |
| GNPX | ▲ Buy | Grant | 200,000 | $0 | 2/18/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
GNPX Among Top Movers in Monday After-Hours Session
Genprex (GNPX) was listed among the top gainers and losers in Monday's after-hours trading, according to market trackers. This movement places the stock in focus within the broader health care sector's post-market activity. The company's stock is currently trading near its 52-week low, with technical indicators showing oversold conditions.
GNPX Among Top Movers in Monday After-Hours Session. Genprex (GNPX) was listed among the top gainers and losers in Monday's after-hours trading, according to market trackers. This movement places the stock in focus within the broader health care sector's post-market activity. The company's stock is currently trading near its 52-week low, with technical indicators showing oversold conditions.